This report studies the Biosimilar Drug market, covering market size for segment by type (Injection, Tablets, etc.), by application (Ankylosing Spondylitis, Tumor, etc.), by Sales Channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
ALSO READ : http://www.marketwatch.com/story/biosimilar-drug-market-research-re...
Since the pandemic of COVID-19 is still raging, The COVID-19 will have a certain impact on this global market. This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends.
This report provides detailed historical analysis of global market for Biosimilar Drug from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biosimilar Drug market.
ALSO READ : http://www.marketwatch.com/story/enterprise-business-analytics-soft...
Leading players of Biosimilar Drug including:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Market split by Type, can be divided into:
Injection
Tablets
Other Types
Market split by Application, can be divided into:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
ALSO READ : http://www.marketwatch.com/story/worldwide-shape-memory-alloy-marke...
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
ALSO READ : http://www.marketwatch.com/story/pta-market-research-report-with-si...
Table of Contents
Chapter 1 Biosimilar Drug Market Overview
1.1 Biosimilar Drug Definition
1.2 Global Biosimilar Drug Market Size Status and Outlook (2015-2030)
1.3 Global Biosimilar Drug Market Size Comparison by Region (2015-2030)
1.4 Global Biosimilar Drug Market Size Comparison by Type (2015-2030)
1.5 Global Biosimilar Drug Market Size Comparison by Application (2015-2030)
1.6 Global Biosimilar Drug Market Size Comparison by Sales Channel (2015-2030)
1.7 Biosimilar Drug Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Biosimilar Drug Market Segment Analysis by Player
2.1 Global Biosimilar Drug Sales and Market Share by Player (2018-2020)
2.2 Global Biosimilar Drug Revenue and Market Share by Player (2018-2020)
2.3 Global Biosimilar Drug Average Price by Player (2018-2020)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biosimilar Drug Market Segment Analysis by Type
3.1 Global Biosimilar Drug Market by Type
3.1.1 Injection
3.1.2 Tablets
3.1.3 Other Types
3.2 Global Biosimilar Drug Sales and Market Share by Type (2015-2020)
3.3 Global Biosimilar Drug Revenue and Market Share by Type (2015-2020)
3.4 Global Biosimilar Drug Average Price by Type (2015-2020)
3.5 Leading Players of Biosimilar Drug by Type in 2020
3.6 Conclusion of Segment by Type
Chapter 4 Biosimilar Drug Market Segment Analysis by Application
4.1 Global Biosimilar Drug Market by Application
4.1.1 Ankylosing Spondylitis
4.1.2 Tumor
4.1.3 Rheumatoid Arthrtis
4.1.4 Cardiovascular
4.1.5 Other Application
4.2 Global Biosimilar Drug Revenue and Market Share by Application (2015-2020)
4.3 Leading Consumers of Biosimilar Drug by Application in 2020
4.4 Conclusion of Segment by Application
Chapter 5 Biosimilar Drug Market Segment Analysis by Sales Channel
5.1 Global Biosimilar Drug Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biosimilar Drug Revenue and Market Share by Sales Channel (2015-2020)
5.3 Leading Distributors/Dealers of Biosimilar Drug by Sales Channel in 2020
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biosimilar Drug Market Segment Analysis by Region
6.1 Global Biosimilar Drug Market Size and CAGR by Region (2015-2030)
6.2 Global Biosimilar Drug Sales and Market Share by Region (2015-2020)
6.3 Global Biosimilar Drug Revenue and Market Share by Region (2015-2020)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biosimilar Drug Market Share by Type
6.4.3 North America Biosimilar Drug Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biosimilar Drug Market Share by Type
6.5.3 Europe Biosimilar Drug Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biosimilar Drug Market Share by Type
6.6.3 Asia-Pacific Biosimilar Drug Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biosimilar Drug Market Share by Type
6.7.3 South America Biosimilar Drug Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biosimilar Drug Market Share by Type
6.8.3 Middle East & Africa Biosimilar Drug Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biosimilar Drug Players
7.1 Roche
ALSO READ : http://www.marketwatch.com/story/auto-suspension-system-market-rese...
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Roche
7.2 Amgen
7.3 AbbVie
7.4 Sanofi-Aventis
7.5 Johnson & Johnson
7.6 Pfizer
7.7 Novo Nordisk
7.8 Eli Lilly
7.9 Novartis
7.10 Merck
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian
7.14 Biotech
7.15 Gelgen
7.16 Innovent
7.17 Dong Bao
7.18 Ganlee
Chapter 8 Upstream and Downstream Analysis of Biosimilar Drug
8.1 Industrial Chain of Biosimilar Drug
8.2 Upstream of Biosimilar Drug
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Biosimilar Drug
8.3.1 Leading Distributors/Dealers of Biosimilar Drug
8.3.2 Leading Consumers of Biosimilar Drug
Chapter 9 Development Trend of Biosimilar Drug (2021-2030)
9.1 Global Biosimilar Drug Market Size (Sales and Revenue) Forecast (2021-2030)
9.2 Global Biosimilar Drug Market Size and CAGR Forecast by Region (2021-2030)
9.3 Global Biosimilar Drug Market Size and CAGR Forecast by Type (2021-2030)
9.4 Global Biosimilar Drug Market Size and CAGR Forecast by Application (2021-2030)
9.5 Global Biosimilar Drug Market Size and CAGR Forecast by Sales Channel (2021-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Biosimilar Drug Example
Figure Global Biosimilar Drug Revenue (Million $) Status and Outlook (2015-2030)
Figure Global Biosimilar Drug Revenue (Million $) Comparison by Region (2015-2030)
Figure Global Biosimilar Drug Revenue (Million $) Comparison by Type (2015-2030)
Figure Global Biosimilar Drug Revenue (Million $) Comparison by Application (2015-2030)
Figure Global Biosimilar Drug Revenue (Million $) Comparison by Sales Channel (2015-2030)
Table Global Biosimilar Drug Sales by Player (2018-2020)
Table Global Biosimilar Drug Sales Market Share by Player (2018-2020)
Figure Global Biosimilar Drug Sales Market Share by Player in 2020
Table Global Biosimilar Drug Revenue (Million $) by Player (2018-2020)
Table Global Biosimilar Drug Revenue Market Share by Player (2018-2020)
Figure Global Biosimilar Drug Revenue Market Share by Player in 2020
Table Global Biosimilar Drug Average Price by Player (2018-2020)
Figure Global Biosimilar Drug Average Price by Player in 2020
Figure Global Biosimilar Drug Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018
Figure Global Biosimilar Drug Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020
Figure Example of Injection
Figure Global Injection Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Tablets
Figure Global Tablets Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Other Types
Figure Global Other Types Revenue (Million $) and Growth Rate (2015-2020)
Table Global Biosimilar Drug Sales by Type (2015-2020)
Table Global Biosimilar Drug Sales Market Share by Type (2015-2020)
Figure Global Biosimilar Drug Sales Market Share by Type in 2020
Table Global Biosimilar Drug Revenue (Million $) by Type (2015-2020)
Table Global Biosimilar Drug Revenue Market Share by Type (2015-2020)
Figure Global Biosimilar Drug Revenue Market Share by Type in 2020
Table Global Biosimilar Drug Average Price by Type (2015-2020)
Figure Global Biosimilar Drug Average Price by Type in 2020
Table Leading Players of Biosimilar Drug by Type in 2020
Figure Example of Ankylosing Spondylitis
Figure Global Biosimilar Drug for Ankylosing Spondylitis Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Tumor
Figure Global Biosimilar Drug for Tumor Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Rheumatoid Arthrtis
....continued

CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105